According to Nova One Advisor, the global cell and gene therapy manufacturing market size is reached at USD 26.67 billion in ...
The surge is fueled by a rapidly expanding gene and cell therapy pipeline, with over 4,000 therapies in development and more ...
The Director of the San Raffaele-Telethon Institute for Gene Therapy Luigi Naldini reflects on what a recent Nature study reveals and about the future of in vivo gene transfer “Our study provides an ...
The re-transcribed DNA is then integrated into the genome of the host cell (Figure 2). This process requires the absence of the nuclear membrane and thus is restricted to the M-phase of proliferating ...
Viral vectors are critical vehicles for the delivery of life-saving cell and gene therapies. Adeno-associated virus (AAV) and lentiviral vectors (LVV), two of the most widely used vector platforms, ...
Oxford, major contract manufacturer to cell and gene therapy companies, has already rejected multiple, unsolicited ...
DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, ...
CRF acquired Spark Therapeutics, Inc.’s SPK-7001 CHM gene therapy assets and is analyzing long-term data to identify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results